Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]
News [3751]
Articles [25]
Editorials [1]
Conferences [142]
elearning [0]
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston...
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Sep 2022
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine...
Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht...
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy ( Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht, Netherlands )
11 Sep 2022
Atezolizumab added to chemo fails to improve PFS in relapsed ovarian cancer
Prof Jean Emmanuel Kurtz - Strasbourg Cancer Institute, Strasbourg, France
Atezolizumab added to chemo fails to improve PFS in relapsed ovarian cancer ( Prof Jean Emmanuel Kurtz - Strasbourg Cancer Institute, Strasbourg, France )
10 Sep 2022
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly...
Dr John B Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma ( Dr John B Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2022
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
22 Aug 2022
Working to improve global cancer care access in low middle-income countries
Dr Julie Gralow, Prof Eduardo Cazap
Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )
25 Jul 2022
Impact of BRAF-V600E mutation on the tumour microenvironment and associated...
Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA
Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer ( Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA )
20 Jul 2022
ASCO Direct Highlights 2022: prostate cancer highlights
Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA
ASCO Direct Highlights 2022: prostate cancer highlights ( Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA )
9 Jul 2022
ASCO Direct Highlights 2022: lung cancer highlights
Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA
ASCO Direct Highlights 2022: lung cancer highlights ( Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA )
9 Jul 2022
Updates in bladder, kidney and testes cancer from ASCO 2022
Dr Winston Tan - Mayo Clinic, Jacksonville, USA
Updates in bladder, kidney and testes cancer from ASCO 2022 ( Dr Winston Tan - Mayo Clinic, Jacksonville, USA )
9 Jul 2022
Latest updates in treatment for the field of HER2-positive breast cancer
Dr Delia Guaqueta - Memorial Healthcare System, Hollywood, USA
Latest updates in treatment for the field of HER2-positive breast cancer ( Dr Delia Guaqueta - Memorial Healthcare System, Hollywood, USA )
8 Jul 2022
Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly...
Dr Anna Sureda - Blood Cell Barcelona Hematology Institute, Barcelona, Spain
Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma ( Dr Anna Sureda - Blood Cell Barcelona Hematology Institute, Barcelona, Spain )
1 Jul 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation